Patents by Inventor Mark C. Siracusa

Mark C. Siracusa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CARBONIC ANHYDRASE ENZYMES FOR REGULATING MAST CELL HEMATOPOIESIS AND TYPE 2 INFLAMMATION
    Publication number: 20230149403
    Abstract: The invention provides methods and compositions that are useful for treating allergic diseases, bacterial infections, fungal infections, viral infections, mastocytosis, mast cell-mediated inflammation and parasite infections (e.g., helminth infections).
    Type: Application
    Filed: June 30, 2022
    Publication date: May 18, 2023
    Applicant: Rutgers, the State University of New Jersey
    Inventor: Mark C. Siracusa
  • Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation
    Patent number: 11406637
    Abstract: The invention provides methods and compositions that are useful for treating allergic diseases, bacterial infections, fungal infections, viral infections, mastocytosis, mast cell-mediated inflammation and parasite infections (e.g., helminth infections).
    Type: Grant
    Filed: July 28, 2020
    Date of Patent: August 9, 2022
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventor: Mark C. Siracusa
  • METHODS OF REDUCING TYPE 2 CYTOKINE-MEDIATED INFLAMMATION USING NEUROMEDIN PEPTIDES
    Publication number: 20210346462
    Abstract: Methods are provided for reducing type 2 cytokine-mediated inflammation, for example by reducing IL-5 and Il-13 activity, using native and variant neuromedin B (Nmb) peptides or coding sequences. Such methods can be used to treat an inflammatory disorder, such as asthma, COPD or an allergic reaction. Also provided are modified Nmb peptides.
    Type: Application
    Filed: October 3, 2019
    Publication date: November 11, 2021
    Applicant: Rutgers, The State University of New Jersey
    Inventors: Mark C. Siracusa, Jacques Y. Roberge
  • CARBONIC ANHYDRASE ENZYMES FOR REGULATING MAST CELL HEMATOPOIESIS AND TYPE 2 INFLAMMATION
    Publication number: 20210052590
    Abstract: The invention provides methods and compositions that are useful for treating allergic diseases, bacterial infections, fungal infections, viral infections, mastocytosis, mast cell-mediated inflammation and parasite infections (e.g., helminth infections).
    Type: Application
    Filed: July 28, 2020
    Publication date: February 25, 2021
    Applicant: Rutgers, the State University of New Jersey
    Inventor: Mark C. Siracusa
  • Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation
    Patent number: 10758537
    Abstract: The invention provides methods and compositions that are useful for treating allergic diseases, bacterial infections, fungal infections, viral infections, mastocytosis, mast cell-mediated inflammation and parasite infections (e.g., helminth infections).
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: September 1, 2020
    Assignee: Rutgers, The State University of New Jersey
    Inventor: Mark C. Siracusa
  • CARBONIC ANHYDRASE ENZYMES FOR REGULATING MAST CELL HEMATOPOIESIS AND TYPE 2 INFLAMMATION
    Publication number: 20180263982
    Abstract: The invention provides methods and compositions that are useful for treating allergic diseases, bacterial infections, fungal infections, viral infections, mastocytosis, mast cell-mediated inflammation and parasite infections (e.g., helminth infections).
    Type: Application
    Filed: August 12, 2016
    Publication date: September 20, 2018
    Applicant: Rutgers, The State University of New Jersey
    Inventor: Mark C. Siracusa